| Heather Mitchell, MS | |
|
1211 N Shartel Ave, Suite 200, Oklahoma City, OK 73103-2400 | |
| (405) 355-3239 | |
| Not Available |
| Full Name | Heather Mitchell |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1211 N Shartel Ave, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003178542 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 146010165 (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Heather Mitchell, MS 1211 N Shartel Ave, Suite 200, Oklahoma City, OK 73103-2400 Ph: (405) 355-3239 | Heather Mitchell, MS 1211 N Shartel Ave, Suite 200, Oklahoma City, OK 73103-2400 Ph: (405) 355-3239 |
News Archive
A new voter survey sponsored by the ACT-AD Coalition (Accelerate Cure/Treatments for Alzheimer's Disease) finds that three-quarters of Americans nationwide and across party lines say it is personally important to them to find a cure or to prevent Alzheimer's disease, while a similar proportion of the national electorate say they look to Congress to make it "a national priority" to speed up the Food and Drug Administration's (FDA) review process in specific ways for therapies that slow, halt or reverse the disease.
A child's smile is something we take for granted. But muscle dysfunction can turn a simple expression of joy into a challenge. Surface electromyography provides a noninvasive method of sensing muscle activity that can be used for muscle rehabilitation—and to bring a smile to a child's face.
Patients living with severe mental illness are being helped to return to work courtesy of new research from Sydney's Westmead Institute for Medical Research.
Youjia Guo et al. in a recent bioRxiv preprint paper demonstrate the robust performance of mouse anti-SARS-CoV-2 spike monoclonal antibodies in immunoassays, including western blotting, ELISA, immunofluorescence, and immunoprecipitation and also neutralizing activity in vitro against SARS-CoV-2 infection.
Avila Therapeutics™, Inc., a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, today announced results of preclinical studies demonstrating that its clinical candidate, AVL-292, potently inhibits B cell receptor signaling, and demonstrates efficacy in a rodent model of rheumatoid arthritis. These new data were presented Saturday, June 26, 2010 at the Federation of Clinical Immunology Societies (FOCIS) 2010 annual meeting in Boston, MA.
› Verified 7 days ago
Ms. Shanun Micaela Gibson, M.S.,CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9031 Sw 29th St, Oklahoma City, OK 73179 Phone: 405-732-3946 Fax: 405-261-6311 | |
Mitsie Shurtz, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3030 Nw Expwy Ste 809, Oklahoma City, OK 73112 Phone: 405-917-7160 | |
Hannah Lopez, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5701 Se 74th St, Oklahoma City, OK 73135 Phone: 405-610-1909 Fax: 405-910-1910 | |
Mrs. Rheagan Diane Ballard, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2828 Nw 57th St Ste 100, Oklahoma City, OK 73112 Phone: 405-286-3749 | |
Leigh Hibbard, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13819 Quail Pointe Dr, Oklahoma City, OK 73134 Phone: 405-467-6782 | |
Priscilla Phillips, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 309 Sw 59th St Ste 305, Oklahoma City, OK 73109 Phone: 405-355-3239 |